Abstract
A uniformly fatal lobar pneumonia was produced in white rats by inoculation of the left main bronchus with virulent Type I pneumococci suspended in mucin. All of the animals succumbed in less than 5 days, half of them dying within 48 hours. In only 5 of 40 rats was the lesion confined to the left lung, and all but one developed pleurisy, pericarditis, or both. All had bacteriemia at the time of death. The pathogenesis of the pulmonary lesion was studied by examining the lungs of 35 rats killed at various intervals following inoculation. The pneumonic process spread rapidly until most of the left lung was involved in 36 hours. Frequent blood cultures showed invasion of the blood stream in a few rats at 6 hours and in over 90 per cent at the end of the first day. The first signs of pleurisy usually appeared at 18 hours. Microscopic examination of the actively spreading lesion revealed three characteristic zones: (1) an outer "edema zone" in which the alveoli contained many pneumococci floating freely in edema fluid, (2) a middle zone where both leucocytes and organisms were present, many of the latter being phagocytized, and (3) an inner zone of advanced consolidation in which the alveoli contained many leucocytes but no organisms and where there were already local areas of early resolution. Study of numerous lesions, at intervals of from 12 to 36 hours after inoculation, indicated that the pneumococci spread into normal alveoli principally by way of the infected edema fluid in the outer zone. Pneumococcus-laden edema fluid in large bronchi and in alveoli beneath the pleura suggested the mode of spread of the infection to other lobes and possibly to the pleural cavity. No adequate explanation could be found for the presence of active phagocytosis in the lungs of animals with bacteriemia and presumably without circulating antibodies, but this conspicuous phagocytic reaction was obviously responsible for the clearing of the central part of the spreading lesion. The action of type specific antibody upon the pulmonary lesion of experimental lobar pneumonia was studied in rats similarly infected but treated with antipneumococcal serum. When injected intravenously in a single dose within 18 hours after inoculation the antiserum was found to protect all of the rats against the otherwise fatal pneumonia. It stopped the spread of the pneumonic lesion, cleared the blood stream of organisms, and prevented the extension of early pleurisy. The antibody caused agglutination and capsular swelling of the pneumococci in the lung, particularly in the edema zone at the margin of the lesion where they were most numerous. Apparently immobilized by agglutination the organisms were overtaken by leucocytes and destroyed by phagocytosis. The phagocytic reaction was greatly accelerated by the specific opsonins of the antiserum, and the pneumococci were destroyed by polymorphonuclear leucocytes before many macrophages appeared in the alveolar exudate. Within a week after treatment resolution of the pulmonary lesion was well in progress. Both horse and rabbit antibody were shown to penetrate the lung, and immune bodies were demonstrated in the alveoli within 10 minutes after the start of treatment. The relation of the observed phenomena to the curative action of anti-pneumococcal serum has been briefly discussed, and it is pointed out that the principal effect of antiserum is to cause immobilization of the pneumococci in the advancing edema zone. Experiments to be reported in a later publication have shown that sulfapyridine exerts a similar effect through a different mechanism.
Full Text
The Full Text of this article is available as a PDF (4.6 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blake F. G., Cecil R. L. STUDIES ON EXPERIMENTAL PNEUMONIA : II. PATHOLOGY AND PATHOGENESIS OF PNEUMOCOCCUS LOBAR PNEUMONIA IN MONKEYS. J Exp Med. 1920 Mar 31;31(4):445–474. doi: 10.1084/jem.31.4.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Branch A., Stillman E. G. PATHOLOGY OF EXPERIMENTAL PNEUMOCOCCUS PNEUMONIA IN MICE. J Exp Med. 1924 Nov 30;40(6):743–752. doi: 10.1084/jem.40.6.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bull C. G. THE MECHANISM OF THE CURATIVE ACTION OF ANTIPNEUMOCOCCUS SERUM. J Exp Med. 1915 Oct 1;22(4):457–464. doi: 10.1084/jem.22.4.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finland M., Spring W. C., Lowell F. C. IMMUNOLOGICAL STUDIES ON PATIENTS WITH PNEUMOCOCCIC PNEUMONIA TREATED WITH SULFAPYRIDINE. J Clin Invest. 1940 Jan;19(1):179–199. doi: 10.1172/JCI101110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamburger M., Robertson O. H. STUDIES ON THE PATHOGENESIS OF EXPERIMENTAL PNEUMOCOCCUS PNEUMONIA IN THE DOG : I. SECONDARY PULMONARY LESIONS. RELATIONSHIP OF BRONCHIAL OBSTRUCTION AND DISTRIBUTION OF PNEUMOCOCCI TO THEIR INCEPTION. J Exp Med. 1940 Aug 31;72(3):261–274. doi: 10.1084/jem.72.3.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heidelberger M., Pedersen K. O. THE MOLECULAR WEIGHT OF ANTIBODIES. J Exp Med. 1937 Feb 28;65(3):393–414. doi: 10.1084/jem.65.3.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jourdonais L., Nungester W. J. INTRATRACHEAL INOCULATIONS IN THE RAT. Science. 1935 Jan 18;81(2090):74–74. doi: 10.1126/science.81.2090.74. [DOI] [PubMed] [Google Scholar]
- Kline B. S., Winternitz M. C. STUDIES UPON EXPERIMENTAL PNEUMONIA IN RABBITS : VIII. INTRA VITAM STAINING IN EXPERIMENTAL PNEUMONIA, AND THE CIRCULATION IN THE PNEUMONIC LUNG. J Exp Med. 1915 Apr 1;21(4):311–319. doi: 10.1084/jem.21.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lord F. T., Persons E. L. CERTAIN ASPECTS OF MOUSE PROTECTION TESTS FOR ANTIBODY IN PNEUMOCOCCUS PNEUMONIA. J Exp Med. 1931 Jan 31;53(2):151–158. doi: 10.1084/jem.53.2.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nye R. N., Harris A. H. Viable Pneumococci and Pneumococcic Specific Soluble Substance in the Lungs from Cases of Lobar Pneumonia. Am J Pathol. 1937 Sep;13(5):749–767. [PMC free article] [PubMed] [Google Scholar]
- Permar H. H. The Mononuclear Phagocytes in Experimental Pneumonia. J Med Res. 1923 Sep;44(1):27–50.1. [PMC free article] [PubMed] [Google Scholar]
- Robertson O. H., Graeser J. B., Coggeshall L. T., Harrison M. A. THE RELATION OF CIRCULATING ANTIPNEUMOCOCCAL IMMUNE SUBSTANCES TO THE COURSE OF LOBAR PNEUMONIA I. NATURAL IMMUNE SUBSTANCES. J Clin Invest. 1934 Jul;13(4):621–631. doi: 10.1172/JCI100610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson O. H., Graeser J. B., Coggeshall L. T., Harrison M. A. THE RELATION OF CIRCULATING ANTIPNEUMOCOCCAL IMMUNE SUBSTANCES TO THE COURSE OF LOBAR PNEUMONIA II. ACQUIRED IMMUNE SUBSTANCES. J Clin Invest. 1934 Jul;13(4):633–647. doi: 10.1172/JCI100611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson O. H., Loosli C. G. A STUDY OF THE MACROPHAGE REACTION IN THE PULMONARY LESIONS OF DOGS WITH EXPERIMENTAL PNEUMOCOCCUS LOBAR PNEUMONIA. J Exp Med. 1938 Mar 31;67(4):575–596. doi: 10.1084/jem.67.4.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson O. H., Sia R. H. STUDIES ON PNEUMOCOCCUS GROWTH INHIBITION : VII. THE RELATION OF OPSONINS TO NATURAL RESISTANCE AGAINST PNEUMOCOCCUS INFECTION. J Exp Med. 1927 Jul 31;46(2):239–262. doi: 10.1084/jem.46.2.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spring W. C., Lowell F. C., Finland M. STUDIES ON THE ACTION OF SULFAPYRIDINE ON PNEUMOCOCCI. J Clin Invest. 1940 Jan;19(1):163–177. doi: 10.1172/JCI101109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Terrell E. E. CHANGES IN HUMORAL IMMUNITY OCCURRING DURING THE EARLY STAGES OF EXPERIMENTAL PNEUMOCOCCUS INFECTION. J Exp Med. 1930 Feb 28;51(3):425–440. doi: 10.1084/jem.51.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ward H. K., Enders J. F. AN ANALYSIS OF THE OPSONIC AND TROPIC ACTION OF NORMAL AND IMMUNE SERA BASED ON EXPERIMENTS WITH THE PNEUMOCOCCUS. J Exp Med. 1933 Mar 31;57(4):527–547. doi: 10.1084/jem.57.4.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wood W. B. THE CONTROL OF THE DOSAGE OF ANTISERUM IN THE TREATMENT OF PNEUMOCOCCAL PNEUMONIA. II. THE CLINICAL APPLICATION OF THE FRANCIS SKIN TEST. J Clin Invest. 1940 Jan;19(1):105–121. doi: 10.1172/JCI101105. [DOI] [PMC free article] [PubMed] [Google Scholar]